@Bayer

Health for All, Hunger for None. That’s what drives us at Bayer.

 Leverkusen, Germany
bayer.com/en/glob-tw-bayer-en-dps-imprint
Joined April 2010
  • Tweets11.4K
  • Following883
  • Followers172K
5KMedia
NEW: A Bayer-commissioned report, with analysis by @OxfordEconomics, finds that the EU and UK risk falling further behind global agricultural competitors as climate & geopolitical pressures grow. Read the news here: spr.ly/6011BHycdN
1
5
967
xitter.cf/BayerUS/status/2106131…
Bayer U.S. 🇺🇸
@BayerUSOct 2
Bayer plans to invest $2.2 billion in a new pharmaceutical manufacturing campus in New Albany, Ohio - bringing manufacturing closer to patients and supporting the reliable production of innovative medicines at scale. Learn more: bayer.com/media/en-us/bayer-…
Bayer plans to invest $2.2 billion in a new pharmaceutical manufacturing campus in New Albany, Ohio - rendering

ALT Bayer plans to invest $2.2 billion in a new pharmaceutical manufacturing campus in New Albany, Ohio - rendering

6
4
1
20
3,700
#NEWS: Bayer showcases its R&D pipeline at field event in Huxley, Iowa: 10 innovations each projected to reach €500M+ in peak sales, with soy trait technology alone expected to surpass €3B. Learn more: spr.ly/6018B1CEi8
8
24
4,814
Earlier today, we published our Half Year 2026 results. Our CEO, Bill Anderson, provides a 90-second overview of the progress we made last quarter and where we will put our focus for the next 90 days. Find out more: spr.ly/6013BE7fvS
12
4
25
4,621
Second quarter of 2026: @Bayer operationally on track to achieve full-year outlook, decisive progress on strategic priorities Here's our digital quarterly statement: spr.ly/6011BE7FqH
2
3
19
4,039
Earlier today, we published our Q1 2026 results. Our CEO, Bill Anderson, provides a 90-second overview of the progress we made and where we will put our focus for the next 90 days. Find out more: bayer.com/en/investors-overv…
34
1
26
4,617
Bayer has reported a solid performance across all divisions for the first quarter and confirmed its currency-adjusted outlook for 2026. Here’s our digital quarterly statement: spr.ly/6018BBt64j
20
4
9
3,156
#News: We intend to acquire Perfuse Therapeutics, a biopharmaceutical company focused on ischemia-induced ocular diseases. Acquisition complements our pharmaceutical pipeline & reinforces our commitment to developing urgently needed therapies for patients: bayer.com/media/en-us/
12
5
15
3,481
Earlier today, we published our Full Year 2025 results. Our CEO, Bill Anderson, provides a 90-second overview of the progress we made and where we will put our focus for the next 90 days. Find out more: reports.bayer.com/annual-rep…
25
6
1
34
7,025
Bayer achieved its upgraded full-year targets for 2025 and shared the company’s outlook for 2026. Here’s our digital annual report: spr.ly/6013hfo4d
6
4
17
4,971
Update on Roundup Litigation: Today, a proposed U.S. nationwide class settlement was announced, designed to resolve eligible current and future RoundupTM claims through a long-term claims program. More details can be found in the link below. youtu.be/d0hIMgwy1Nw
38
8
2
21
14,885
bayer.com/media/en-us/monsan…

Monsanto announces Roundup™ class settlement agreement to resolve current and future claims

Class settlement and the U.S. Supreme Court case are independently necessary and mutually reinforcing elements in multi-pronged strategy to significantly contain the litigation / Funding of the class...

bayer.com
14
3
10
3,597
NEW EPISODE of Long Strange Trip with Bill Anderson, CEO of @Bayer, just dropped. This episode is a master class in going Founder Mode. In 2 years he's torn down and rebuilt how a 160-year-old company operates. I hope you enjoy it. Leave a comment and let me know what struck you most.
18
10
1
53
11,472
#NEWS: Bayer presented for the first time detailed results of a pivotal Phase III study in secondary stroke prevention at the International Stroke Conference (ISC) 2026. Learn more: bayer.com/media/en-us/
9
4
17
2,985
The U.S. Supreme Court today announced that it will review the Durnell Roundup case. The company expects a decision on the merits during the Court’s 2026 session, which ends in June. Link to press release: bayer.com/media/en-us/bayer-…

Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation

Decision on the merits expected by June 2026 / Favorable outcome would contribute to significantly containing the Roundup™ litigation as the company continues its multi-pronged strategy

bayer.com
12
7
5
22
4,885
#NEWS: The European Commission grants marketing authorization in the EU for an eye medication with long injection intervals for macular edema following retinal vein occlusion (RVO). #RVO affects 28M adults and can cause sudden vision loss.
6
2
1
6
2,901
#NEWS: The EU Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommends an eye medication with extended dosing intervals for approval in the treatment of macular edema following retinal vein occlusion.

EMA has recommended an eye medication with extended dosing intervals.

EMA has recommended an eye medication with extended dosing intervals for approval in the treatment of macular edema following retinal vein occlusion.

13
2
10
2,972
+++ Exciting #news ++ Bayer announces positive topline results from the international Phase III study. #TeamBayer #HealthForAll #HungerForNone

+++ Exciting #news +++

Bayer announces positive topline results from its international Phase III study in secondary stroke prevention.

22
10
27
5,816
#News: The European Commission has approved our new hormone-free treatment option for vasomotor symptoms (VMS; also known as hot flashes) associated with menopause or caused by endocrine therapy for breast cancer.
7
3
9
3,318
Earlier today, we published our Q3 2025 results. Our CEO, Bill Anderson, provides a 90-second overview of the progress we made and where we will put our focus for the next 90 days: youtube.com/watch?v=q2pqbzNd…
7
6
1
16
2,604
Load more